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Abstract
Background: Krüppel-like factor 9 (KLF9) is a transcriptional regulator of uterine endometrial cell
proliferation, adhesion and differentiation; processes essential for pregnancy success and which are
subverted during tumorigenesis. The network of endometrial genes controlled by KLF9 is largely
unknown. Over-expression of KLF9 in the human endometrial cancer cell line HEC-1-A alters cell
morphology, proliferative indices, and differentiation, when compared to KLF9 under-expressing HEC-1-
A cells. This cell line provides a unique model for identifying KLF9 downstream gene targets and signaling
pathways.
Methods: HEC-1-A sub-lines differing in relative levels of KLF9 were subjected to microarray analysis to
identify differentially-regulated RNAs.
Results:  KLF9 under-expression induced twenty four genes. The KLF9-suppressed mRNAs encode
protein participants in: aldehyde metabolism (AKR7A2, ALDH1A1); regulation of the actin cytoskeleton
and cell motility (e.g., ANK3, ITGB8); cellular detoxification (SULT1A1, ABCC4); cellular signaling (e.g.,
ACBD3, FZD5, RAB25, CALB1); and transcriptional regulation (PAX2, STAT1). Sixty mRNAs were more
abundant in KLF9 over-expressing sub-lines. The KLF9-induced mRNAs encode proteins which participate
in: regulation and function of the actin cytoskeleton (COTL1, FSCN1, FXYD5, MYO10); cell adhesion,
extracellular matrix and basement membrane formation (e.g., AMIGO2, COL4A1, COL4A2, LAMC2,
NID2); transport (CLIC4); cellular signaling (e.g., BCAR3, MAPKAPK3); transcriptional regulation [e.g.,
KLF4, NR3C1 (glucocorticoid receptor), RXRα], growth factor/cytokine actions (SLPI, BDNF); and
membrane-associated proteins and receptors (e.g., CXCR4, PTCH1). In addition, the abundance of
mRNAs that encode hypothetical proteins (KLF9-inhibited: C12orf29 and C1orf186; KLF9-induced:
C10orf38 and C9orf167) were altered by KLF9 expression. Human endometrial tumors of high tumor
grade had decreased KLF9 mRNA abundance.
Conclusion:  KLF9 influences the expression of uterine epithelial genes through mechanisms likely
involving its transcriptional activator and repressor functions and which may underlie altered tumor
biology with aberrant KLF9 expression.
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Background
Krüppel-like factor 9 (KLF9), previously referred to as
Basic Transcription Element Binding (BTEB) Protein 1, is
an evolutionarily well-conserved member of the Krüppel-
like factor (KLF) family of transcriptional regulators, so
named for the presence of Drosophila Krüppel-like DNA-
binding domain(s) in the protein's C-terminal region [1].
KLFs function as transcriptional activators or repressors,
depending upon cellular context and presence of partner
co-regulators [1,2]. Individual KLF proteins affect cell pro-
liferation, differentiation, apoptosis, DNA damage, and
stress responses [2]. Members of this family have been
implicated in stem cell renewal, maintenance of pluripo-
tency, lineage determination, organogenesis, and onco-
genesis [2-5], underscoring their wide-ranging regulatory
roles in development.
KLF9 was first isolated and identified as trans-repressor of
the rat liver CYP1A1 gene and inducer of SV40 early and
HIV-1 long terminal repeat promoters [6,7]. Subsequent
work demonstrated KLF9 activation of the liver CYP7A
gene [8]. Albeit trans-activation and trans-repression func-
tions of KLF9 are mediated by formation of different tran-
scriptional protein complexes, they occur through KLF9
binding to highly similar GC/GT boxes [2,6,7]. KLF9
mRNA is expressed at highest levels in rat brain, kidney,
lung and testis [6]. Potential brain functions for KLF9
have been recently elucidated. This transcription factor is
induced in rat brain by 3, 5, 3'-triiodothyronine (T3) and
mediates effects of T3 on neuronal process development
[9-11]. Mice lacking KLF9 exhibited deficits in motor
learning, motor coordination and fear-conditioning [12].
Recently, KLF9 was shown to regulate crypt-villus cell
renewal in mice [13] and secondary antibody responses of
human splenic B cells [14].
The uterus is a complex organ that exhibits hormonally
(estrogen, progesterone) driven changes in the expression
of myriad genes and gene products during the estrous
cycle and pregnancy. Morphologically, the uterus is com-
prised of epithelium (glandular and luminal), stromal
fibroblasts, immune cells, and myometrium. Regulatory
actions of KLF9 in the uterus during development and
pregnancy have been partially elucidated by our laborato-
ries. Mice null for KLF9 exhibited uterine hypoplasia,
smaller litter size, reduced numbers of implantation sites,
partial progesterone resistance in the uterus, and delayed
parturition [15,16]. The sub-fertility phenotype of the
KLF9 knockout mouse was shown to correlate with aber-
rant timing of uterine stromal and epithelial proliferation
during the peri-implantation period, suggesting an out-of-
phase uterus relative to blastocyst development as poten-
tially causative for sub-fertility of KLF9 null females [17].
KLF9 facilitated progesterone-inductive effects on uterine
gene expression by its co-recruitment with the progester-
one receptor [18,19] and inhibited estrogen receptor α
trans-activity by promoting this receptor's estrogen-
induced down-regulation [20].
In previous studies, analysis of estrogen receptor-negative
human endometrial carcinoma (HEC-1-A) cells that were
genetically engineered to over- or under-express KLF9
identified serum-dependent mitogenic functions for this
nuclear protein, based on its influence on cell phenotype
and gene expression changes that support increased pro-
liferation [21,22]. HEC-1-A cells with increased KLF9
expression grew as flat monolayers, whereas those with
less KLF9 tended to round up on plastic, formed multi-
layers, and exhibited dome formation [21]. Because the
repertoire of genes identified in that study was limited and
did not fully explain the potentially opposing functions of
KLF9 on cell adhesion and proliferation, defects of which
may underscore cell survival, migration, invasion, and
tumorigenesis, we have now performed global expression
profiling of the HEC-1-A sub-lines that over- or under-
express KLF9. Results demonstrate prominent effects of
KLF9 on genes encoding basement membrane and ECM
proteins, cell stress response and detoxification pathway
members, uterine endometrial steroid- and estrous cycle-
regulated proteins, and membrane- and nuclear-associ-
ated receptors. These findings correlate with the attenu-
ated expression of KLF9 with high endometrial tumor
grade, thereby suggesting the potential involvement of
KLF9 dys-regulation in both pregnancy failure and
endometrial pathogenesis.
Methods
Cell lines
The generation and initial characterization of the cell lines
used in this study were previously described [21,22]. The
4S and 9S sub-lines were derived from the original human
HEC-1-A endometrial carcinoma cell line and contain a
stably transfected expression plasmid encoding full-
length rat KLF9, whereas the 2AS and 3AS sub-lines con-
tain a stably transfected plasmid encoding an antisense
(AS) RNA to KLF9. The primary sequence of human and
rat KLF9 coding regions are 98% identical [23]. All cell
lines were derived concurrently [21]. The 'sense' (S) and
'antisense' (AS) cell lines differed in relative levels (S > AS)
of KLF9 protein and activity [21]. S sub-lines expressed
~2.4 fold greater immunoreactive KLF9 than AS sub-lines
[21]. The 4S/2AS and 9S/3AS sub-lines were propagated
separately to near confluence and RNA was harvested
using TRIzol reagent (Invitrogen, Carlsbad, CA).
Affymetrix GeneChip technology and bio-informatics
RNA was purified using the RNeasy Mini Kit (QIAGEN,
Valencia, CA) followed by on-column DNA digestion
with RNase-Free DNase (QIAGEN). RNA integrity was
confirmed using the RNA 6000 Nano LabChip (AgilentReproductive Biology and Endocrinology 2008, 6:41 http://www.rbej.com/content/6/1/41
Page 3 of 11
(page number not for citation purposes)
Biotechnologies, Palo Alto, CA). Two replicate cRNA tar-
gets were generated from each HEC-1-A sub-line RNA
preparation; all eight targets were made at the same time.
Total cellular RNA (8 ug) was converted to cDNA using a
T7-(deoxythymidine)24  primer and Superscript II (Life
Technologies, Inc., Gaithersburg, MD). Resulting cDNA
was used with the ENZO BioArray High Yield RNA Tran-
script labeling kit (ENZO, Farmingdale, NY) to synthesize
biotin-labeled cRNA; the latter was purified on an RNeasy
spin column (QIAGEN) and chemically fragmented to a
size range of 35 to 200 bp. cRNAs were concurrently
hybridized to HG-U133A GeneChips (Affymetrix, Santa
Clara, CA). Hybridizations were performed for 16 hours,
followed by incubations with streptavidin-conjugated
phycoerythrin, and polyclonal anti-streptavidin antibody
coupled to phycoerythrin. GeneChips were scanned using
an Agilent GeneArray laser scanner and images analyzed
using Affymetrix MAS 5.0 software. Bacterial sequence-
derived probes on the arrays served as external controls for
hybridization, whereas the housekeeping genes β-actin
and GAPDH served as endogenous controls and for mon-
itoring the quality of the RNA targets.
Unsupervised nearest-neighbor hierarchical clustering
(Spotfire DecisionSite, Somerville, MA) identified a sig-
nificant effect of culture condition/date of RNA collection
on overall gene expression profiles. Therefore, to identify
candidate KLF9 gene targets, the following was separately
performed on the combinations of 4S/2AS and 9S/3AS.
Intensity values of probe sets were imported into Gene-
Spring Gx 7.3 software for analysis. Values were processed
using the Robust Multiarray Analysis algorithm for back-
ground adjustment, normalization and log2-transforma-
tion of perfect match values. Data were subjected to per-
chip and per-gene normalization and analyzed for differ-
ences between cell lines (fold-change, S relative to AS,
value of 1.3 or higher; P < 0.05, Student's t test). Tran-
scripts that passed these filters for both the 4S/2AS and
9S/3AS cell line combinations comprised the final KLF9-
regulated gene lists and were compared for gene overlaps.
The final gene list (comprised only of overlapping tran-
scripts) was annotated using NETAFFX [24] and NCBI Ent-
rez [25]. The microarray data have been deposited in Gene
Expression Omnibus [26] as series GSE11855.
Quantitative real-time RT-PCR (qRT-PCR)
One  μg of total cellular RNA from each cell line was
reverse-transcribed using random hexamers and Multi-
Scribe Reverse Transcriptase in a two-step RT-PCR reaction
(Applied Biosystems, Foster City, CA). Primers (Table 1)
were designed using 'Primer Express' (Applied Biosys-
tems) to yield a single amplicon; this was verified by dis-
sociation curves. SYBR Green real-time PCR was
performed with an ABI Prism 7000 Sequence Detector or
Bio-Rad MyiQ Real-Time PCR Detection System. Thermal
cycling conditions included pre-incubation at 50°C for 2
min, 95°C for 10 min followed by 40 PCR cycles at 95°C
for 15 sec and 60°C for 1 min. Relative transcript levels
were calculated using the relative standard curve method
(User Bulletin #2, Applied Biosystems) and results were
Table 1: Primers used in quantitative real-time RT-PCR
Gene Name Upstream Primer (5'-3') Downstream Primer (5'-3') PCR product size (bp)
18S TCTTAGCTGAGTGTCCCGCG ATCATGGCCTCAGTTCCG A 150
AKR7A2 AACTGGACACGGCCTTCATG CCTTGGTGGCAATTTTCACTCTG 109
ALDH1A1 ACCCCAGGAGTCACTCAAGG ACTGTGGGCTGGACAAAGTAG 149
BCAR3 CCTGGAAATGCCACAGATCAC CTTCATGCAGGAGTTTGCTGAA 124
C1orf186 TAGCTTGGATAGCTCCTGCAGTTC CATTTTTTAGTTCTCCAGGGTCAGA 101
CLIC4 TCACCAAAACACCCAGAATCAA ACCCCTCTCCAGTGCTTCATTA 108
COL4A1 CACGGGTACTCTTTGCTCTACGT AAGGGCATTGTGCTGAACTTG 101
COL4A2 CATGCCCTTCCTGTACTGCAA GATGTACTTGATCTCGTCCT 133
CXCR4 CATCAGTCTGGACCGCTACC GCAAAGATGAAGTCGGGAATAGTC 138
ER-α CGGCATTCTACAGGCCAAATT AGCGAGTCTCCTTGGCAGATT
FZD5 GCTACCAGCCGTCCTTCAGT GAAGCGTTCCATGTCGATGAG 128
KLF4 CTGCGGCAAAACCTACACAAA GAATTTCCATCCACAGCCGT 106
KLF9 TGGCTGTGGGAAAGTCTATGG CTCGTCTGAGCGGGAGAACT
LAMC2 GATGGCATTCACTGCGAGAAG TCGAGCACTAAGAGAACCTTTGG 105
LAPTM5 CATCTTTTCCATCGCCTTCATCAC TCCACCGAGTTCATGCACTTG 102
MAPKAPK3 TCCCACCCTTCTACTCCAACA TTCAACAGGAGGCGGATCA 141
NR3C1 AGAGGAGGAGCTACTGTGAAGG ACTGAGCCTTTTGGAAAATCAACC 109
PAX2 CCCAGAGTGGTGTGGACAGTTT GTAGGAAGGACGCTCAAAGACC 101
PSAT1 ACGCCTCCATGTTTCAGCAT TGAGATTTGATGGAGCTAAGCTTCT 104
PTCH1 GTCGAGCTGTTCGGCATGAT AGCAACGTGAACGGTGAACTC 111
RAB25 GGAGCTCTATGACCATGCTGAA CCAGGAAGAGCAGTCCATTGTT 125
RXRA AGGACTGCCTGATTGACAAGC GACTCCACCTCATTCTCGTTCC 141
SLPI GCTGTGGAAGGCTCTGGAAA TGCCCATGCAACACTTCAAG 298Reproductive Biology and Endocrinology 2008, 6:41 http://www.rbej.com/content/6/1/41
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normalized to 18 S rRNA. Data are reported as mean ±
SEM and were analyzed by one-way ANOVA (SigmaStat;
Systat Software, Inc., Point Richmond, CA). P < 0.05 was
considered to represent a significant difference.
A TissueScan™ endometrial cancer qPCR array was pur-
chased from OriGene Technologies, Inc. (Rockville, MD).
This panel was comprised of a series of normalized cDNAs
prepared from pathologist-verified human endometrium
and endometrial tumors. Ages of tissue donors ranged
from 30 to 87 years.
Results
Gene expression profiling
The 4S/2AS and 9S/3AS pairs of sub-lines were grown on
separate occasions to ~80% confluence. Total cellular
RNAs from the four sub-lines were concurrently subjected
to global gene expression profiling, with each RNA sam-
ple analyzed in duplicate. Unsupervised hierarchical clus-
tering of gene expression profiles for all transcripts
indicated a significant effect of time of experiment (i.e.,
when sub-lines were cultured) (data not shown). We
therefore performed bio-informatic comparisons of 2AS
vs. 4S and 3AS vs. 9S separately, and then searched for
overlap in the differentially expressed transcripts between
each paired comparison. There were more genes expressed
at higher levels in KLF9 sense (S) than antisense (AS) sub-
lines among the differentially expressed transcripts identi-
fied (Figure 1). However, whereas the numbers of KLF9-
induced (160 and 149 for 4S and 9S, respectively) and
KLF9-suppressed (76 and 93 for 2AS and 3AS, respec-
tively) transcripts for each pair of sub-lines were compara-
ble, less than half of these were found to overlap in both
final gene lists for S (total of 60) and AS (24) sub-lines. As
a conservative estimate, these overlapping transcripts were
taken to reflect KLF9 activity and/or expression levels in
the clonal sub-lines. Unsupervised hierarchical clustering
of these signature transcripts demonstrated the close relat-
edness of the S sub-lines expression profiles (Figure 2). As
expected, the expression profiles of the AS sub-lines dif-
fered from the S sub-lines; however, they also differed
from each other (Figure 2).
Transcripts that varied in expression across the two pairs
of sub-lines were annotated for their known or putative
function(s), fold-change, and cellular locations (addi-
tional file 1: Table 1 and additional file 2: Table 2). KLF9
under-expression in HEC-1-A cells (i.e., AS sub-lines)
caused induction in relatively few (twenty four) genes. Six
of these genes/transcripts were examined by qRT-PCR and
all were confirmed to be induced in the AS sub-lines
(Table 2). In general, for a given transcript/gene there was
excellent agreement between the fold-change calculated
from microarray and that from qRT-PCR (Table 2). These
KLF9-suppressed (directly or indirectly) mRNAs encode
proteins which are important participants in: aldehyde
metabolism (AKR7A2, ALDH1A1), regulation of the actin
cytoskeleton and cell motility (e.g., ANK3, ITGB8), cellu-
lar detoxification (SULT1A1, ABCC4), cellular signaling
(e.g., ACBD3, FZD5, RAB25, CALB1), and transcriptional
regulation (PAX2, STAT1). In addition, two hypothetical
proteins (C12orf29, C1orf186) are encoded by mRNAs
whose levels were increased with KLF9 suppression.
Sixty mRNAs were more abundant in 4S and 9S than 2AS
and 3AS sub-lines (Figure 1). We examined a subset of
these (fourteen in total) by qRT-PCR and confirmed their
differential expression (Table 2). KLF9-induced mRNAs
encode proteins which participate in: serine biosynthesis
(e.g., PSAT1, a major progesterone-induced protein of the
rabbit uterus); regulation and function of the actin
cytoskeleton (COTL1, FSCN1, FXYD5, MYO10); cell
adhesion, extracellular matrix and basement membrane
formation (e.g., AMIGO2, COL4A1, COL4A2, LAMC2,
NID2); transport (CLIC4); cellular signaling (e.g., BCAR3,
MAPKAPK3); transcriptional regulation [e.g., KLF4,
NR3C1 (glucocorticoid receptor), RXRα]; growth factors/
cytokine actions (SLPI, BDNF); or are membrane-associ-
ated proteins and receptors (e.g., CXCR4, PTCH1); and
metallothioneins (Table 2; additional file 2: Table 2). In
addition, two mRNAs that encode hypothetical proteins
(C10orf38, C9orf167) were increased in abundance with
KLF9 over-expression.
Differentially expressed transcripts of HEC-1-A sub-lines Figure 1
Differentially expressed transcripts of HEC-1-A sub-
lines. Venn diagrams summarize the number of differentially 
expressed genes noted between 2AS and 4S sub-lines, 
between 3AS and 9S sub-lines, and those in common for 
both comparisons (final annotated gene lists are presented in 
additional file 1: Table 1 and additional file 2: Table 2). There 
were greater numbers of genes induced than repressed in 
concert with relative KLF9 expression.
24
2AS vs. 4S 3AS vs. 9S
60 160 149
“KLF9 – Repressed” Transcripts
“KLF9 – Induced” Transcripts
93 76Reproductive Biology and Endocrinology 2008, 6:41 http://www.rbej.com/content/6/1/41
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Novel human membrane proteins expressed in HEC-1-A 
cells
We confirmed the reduction in abundance of the mRNA
encoding C1orf186 in the KLF9 S sub-lines by qRT-PCR
(Table 2). C1orf186 protein contains 172 amino acid res-
idues and has a predicted mol wt of 19,405 and an isoe-
lectric point of 4.53. Its sequence bears hallmarks of a
single pass trans-membrane protein with multiple poten-
tial serine, threonine and tyrosine phosphorylation sites
in its intracellular face (data not shown). In humans, this
transcript is highly expressed in the uterus where its abun-
dance is regulated by stage of the menstrual cycle [25,26].
A second novel membrane protein-encoding mRNA iden-
tified from our microarray results was that for C9orf167.
In contrast to C1orf186 mRNA, C9orf167 mRNA was
induced by KLF9 in HEC-1-A cells. The protein encoded
by C9orf167 is comprised of 422 amino acids in the
human and is an uncharacterized member of the clpA/
clpB family, Torsin subfamily of proteins. The paralogous
protein in Chimpanzee is 99.8% similar, while the mouse
protein is 84.9% similar to that for the human [25]. This
transcript is ubiquitous in human and mouse tissues with
abundant expression in the uterus; albeit not as dramatic
as for C1orf186, uterine expression of C9orf167 also is
regulated by stage of menstrual cycle in women [25,26].
KLF9 mRNA expression in human uterine tumors
Endometrial cancer is associated with unopposed estro-
gen activity. In Ishikawa endometrial cancer cells, KLF9
opposed ER-α activity and decreased this protein's expres-
sion [20]. Given that KLF9 over-expression increased pro-
liferation [21], and induced the expression of transcripts
encoding multiple ECM and basement membrane com-
ponents for increased adhesion to substratum (additional
file 1: Table 1 and additional file 2: Table 2) in HEC-1-A
cells, it was of interest to examine human endometrial
tumors for expression of KLF9 mRNA. A reduction in
KLF9 mRNA abundance in combined stages II through IV
tumors, compared to normal endometrium and stage I
tumors was observed (Fig. 3).
Hierarchical clustering of differentially expressed RNAs Figure 2
Hierarchical clustering of differentially expressed RNAs. The microarray data for mRNAs that were identified to be 
differentially expressed between S and AS sub-lines (additional file 1: Table 1 and additional file 2: Table 2) were subjected to 
hierarchical clustering. The transcript profiles were very similar for both S sub-lines (each run in duplicate); whereas the two 
AS sub-lines differed from each other and from the S sub-lines. Lower case letters signify duplicate microarrays for each sub-
line.
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Discussion
The present study extended our initial characterization of
HEC-1-A sub-lines which were genetically engineered to
have enhanced or reduced expression of KLF9, relative to
the parental HEC-1-A cell line [21]. Concordant with
KLF9's dual function as a transcriptional activator and
transcriptional repressor, a range of genes involved in dis-
tinct signal transduction pathways was induced or
repressed by KLF9. Using the unbiased microarray
approach, we found significantly more KLF9-induced
than KLF9-repressed transcripts in HEC-1-A sub-lines.
Although the biological significance of this finding is
unclear, it raises the important question of whether cellu-
lar context defines in part, the transcriptional direction of
KLF9 activity, and whether this difference may be under-
scored by distinct interactions of KLF9 with various co-
activators and co-repressors also present. The degree of
overlap of transcripts noted between the two pairs of com-
pared sub-lines was less than anticipated and may reflect
the arbitrary cut-offs used for bio-informatic analysis, the
effects of small differences in culture conditions on mRNA
expression, and the non-specific effects of the process of
clonal sub-line derivation.
In previous studies, we showed that the S lines with higher
KLF9 expression and mitotic index grew as monolayers,
whereas the AS lines with lower KLF9 expression and
mitotic index tended to round up on plastic, formed
multi-layers, and exhibited dome formation [21], the lat-
ter potentially indicative of enhanced tumor invasive
capability and metastasis. Our current findings identified
putative KLF9-regulated genes whose proteins are known
to contribute to basement membrane formation, ECM
formation, cell adhesion, and cytoskeletal organization
and regulation. Of note was the KLF9 up-regulated expres-
sion of the LAMC2 gene, encoding the basement mem-
brane laminin gamma 2 protein, which is important for
epithelial anchoring to substratum. While regulation of
other laminin genes by other KLF family members has
been previously reported [27,28], our findings constitute
the first linkage of KLF9 and laminin gene expression for
any cell type. Basement membranes and extracellular
matrix are dynamic entities that do more than just pas-
sively anchor cells to surfaces; they are, for example,
important modifiers of cellular growth, differentiation,
apoptosis, anoikis and migration. Thus, loss of KLF9 which
regulates secreted and membrane-associated proteins
Table 2: qRT-PCR confirmation of differential expression of selected transcriptsa
4S vs. 2AS (fold) 9S vs. 3AS (fold)
Gene Symbol qRT-PCR Microarray qRT-PCR Microarray
Up-regulated
BCAR3 3.907 2.488 1.171 2.611
CLIC4 31.636 21.46 24.750 11.710
COL4A1 3.387 3.584 1.768 2.179
COL4A2 2.967 7.692 1.834 2.725
CXCR4 5.000 2.762 13.037 3.876
KLF4 4.532 2.110 1.816 3.185
LAMC2 1.633 3.003 2.276 3.676
LAPTM5 22.135 24.331 37.060 5.917
MAPKAPK3 3.665 3.861 7.056 3.831
NR3C1 7.111 2.841 12.500 4.386
PSAT1 1.394 2.278 2.876 6.897
PTCH1 3.572 4.310 3.008 2.242
RXRα 10.953 5.405 5.750 2.445
SLPI 26.636 9.524 4.788 11.779
Down-regulated
ALDHIAI 0.222 0.174 0.109 0.068
AKR7A2 0.647 0.491 0.264 0.387
C1orf186 0.366 0.155 0.278 0.265
FZD5 0.365 0.440 0.552 0.380
PAX2 0.145 0.247 0.041 0.382
RAB25 0.012 0.076 0.002 0.082
aAll fold change values were statistically significant (P < 0.05); n = 2 replicates per cell line.Reproductive Biology and Endocrinology 2008, 6:41 http://www.rbej.com/content/6/1/41
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such as laminin, might constitute an early event in the epi-
thelial-mesenchymal transition, leading to invasion and
subsequent metastasis. Consistent with this, endometrial
tumors of higher grades (and with greater invasion and
metastasis) had decreased KLF9 gene expression com-
pared to normal endometrium and stage I tumors. While
this association is not particularly strong and requires
additional confirmation with increased sample size and
evaluation at the protein level, our data mirrors a recent
report that decreased KLF9 expression also is a feature of
increased grade of colon tumors [29].
Previously, we observed increased KLF5 mRNA abun-
dance in HEC-1-A cells after KLF9 over-expression, with
no differences in mRNA level for Sp1, the best character-
ized transcriptional activator of the Sp/KLF family [22]. In
the present study, this positive association with KLF9 was
similarly noted for KLF4. In colon crypt epithelium, KLF4
mediates growth arrest and induction of the colonic epi-
thelial phenotype, whereas KLF5 stimulates proliferation
of crypt progenitor cells [30,31]. By contrast, KLF13, the
most closely related family member to KLF9 [1] was
found to be inversely associated with KLF9 expression in
uteri of KLF9 null mice, possibly reflective of partial func-
tional compensation [15]. While the roles of KLF4, KLF5
and KLF 13 in normal and tumorigenic uterine epithe-
lium and their regulation by KLF9 are as yet unknown, the
presence of all three members in the uterus suggests a KLF
network where these proteins' cooperative, opposing, or
compensatory functions in the physiological contexts of
uterine remodeling, embryo implantation, tumorigenesis,
and stem cell regulation may be manifest. Indeed, func-
tional KLF networks have been reported in the mainte-
nance of the intestinal epithelial cell phenotype [32], self
renewal of embryonic stem cells [4], and secondary anti-
body response in memory B cells [14].
Previous work from our laboratories has implicated KLF9
in progesterone and estrogen actions in the uterus
[15,17,19,33]. The present results further support these
linkages. PSAT1, an in vivo progesterone-induced gene in
rabbit uterus [34], was more highly expressed in the KLF9
over-expressing HEC-1-A cells. We also found repression
of ALDH1 gene expression and increased levels of CXCR4
and SLPI gene transcripts in KLF9 S cells. In ovariect-
omized mice, uterine ALDH1A1 mRNA was rapidly
induced by progesterone, whereas CXCR4 transcripts were
down-regulated by chronic progesterone treatment [35].
SLPI is a progesterone-induced, secreted anti-protease
with anti-microbial and mitogenic activities for uterine
epithelial cells [36-38]. Expression of the uterine SLPI
gene/protein is increased around the time of implantation
in rodents, pigs, primates and humans in response to
estrogen and progesterone [39-43]. Given the distinct pat-
terns of expression of CXCR4, ALDH1A1 and SLPI genes
with KLF9 in vitro and with progesterone in vivo, results
suggest the functional contribution of KLF9 to progester-
one receptor signaling. In this regard, a recent study from
our laboratories demonstrated the progesterone-depend-
ent co-recruitment of KLF9 and the progesterone receptor
to the SLPI promoter, concomitant with induction of this
gene's expression, in Ishikawa endometrial cancer cells
[19].
We observed that Patched 1 (PTCH1) transcripts were
induced in KLF9 S sub-lines. This gene encodes the recep-
tor for the morphogen Sonic Hedgehog (SHH), a known
stimulator of endometrial cell proliferation in vitro [44].
The related molecule, Indian Hedgehog (IHH), is a pro-
gesterone-induced molecule in the mouse uterus and
mediates effects of progesterone on uterine epithelial-
stromal cell interactions essential for implantation [45].
CXCR4 encodes a chemokine receptor that is up-regulated
during the window of implantation in human
Quantitative RT-PCR of KLF9 mRNA in human  endometrium and endometrial tumors Figure 3
Quantitative RT-PCR of KLF9 mRNA in human 
endometrium and endometrial tumors. A normalized 
cDNA panel of human endometrial tumors was obtained 
from OriGene Technologies, Inc. This panel was comprised 
of cDNAs from n = 6 of normal (N) endometria, n = 9 of 
Stage I tumors, n = 8 of Stage II tumors, n = 19 of Stage III 
tumors, and n = 6 of Stage IV tumors. Shown are box plots 
(median, upper and lower quartiles, minimum and maximum 
data values) of relative abundance of KLF9 mRNA for tumors 
(delineated by stage and tumor type: endometrioid, serous). 
Sample numbers are indicated. ANOVA indicated no differ-
ences in mRNA abundance between any of the individual 
stages. However, a significant difference between combined 
stages (normal plus stage I vs. stages II, III, and IV) was noted 
by the Mann-Whitney Rank Sum test.
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endometrium and which may facilitate blastocyst adhe-
sion to the uterine surface [46-49]. The CXCR4 ligand,
namely stromal cell-derived factor-1α (SDF-1α), pro-
motes proliferation of HEC-1-A cells in vitro through Akt
and ERK1/2 signaling pathways [50]. Thus, up-regulated
expression of PTCH1 and CXCR4 mRNAs with over-
expression of KLF9 may explain the increased mitogenesis
of KLF9 S cell lines observed in vitro [21,22]. CXCR4 is
also a co-receptor for HIV-1, and uterine expression of
HIV receptors/co-receptors may underlie HIV transmis-
sion to women [47]. Moreover, KLF9 is itself a transcrip-
tional inducer of the HIV-1 LTR [7]. The latter data raise
the provocative question of whether KLF9 affects uterine
and vaginal uptake and replication of HIV-1 in vivo, and if
so, whether KLF9 might constitute a genetic modifier of
HIV risk. Further studies are required to evaluate this pos-
sibility as well as the mode of regulation of CXCR4 by
KLF9 in the female reproductive tract.
The power of microarrays is that they often reveal new
participants and novel functional connections in specific
physiological contexts. We found several interesting
examples of these in the present work. Brain-derived neu-
rotrophic factor (BNDF) was observed to be up-regulated
in KLF9 S sub-lines, suggesting BNDF as a downstream
effector of KLF9 signaling. Recently, this soluble factor
was implicated as a mediator of cyclic changes in sympa-
thetic innervation in the uterus and in uterine-embryo
communication [51,52]. We also found that the Frizzled
gene FZD5, which encodes the receptor for the secreted
glycoprotein Wnt 5B, normally expressed in human
endometrium [53] is suppressed by KLF9 in HEC-1-A
cells; suggesting the contribution of KLF9 to the control of
this growth factor-receptor pathway.
We noted the induction of several metallothionein genes
(MT1H, MTH1X, and MT2A) with KLF9 over-expression.
Metallothioneins are expressed in cyclic fashion in human
endometrium with most abundant expression during the
secretory phase, where they may play protective roles dur-
ing cell stress [53,54]. The hyaluronic acid receptor CD44
mRNA also was increased in abundance with KLF9 over-
expression. This molecule is regulated in human
endometrium by stage of menstrual cycle (maximal dur-
ing mid and late secretory phases) [55]. Versican mRNAs
are up-regulated in human endometrium during the mid-
secretory phase [53]; accordingly, we noted increased
expression of this gene with KLF9 over-expression. Thus,
with these genes, KLF9 transactivation was correlated with
secretory phase uterine expression. However, the apparent
repression of SULT1A1 gene by KLF9 in HEC-1-A cells
contrasted with the increased abundance of this gene dur-
ing the secretory relative to the proliferative phase of the
human endometrium [56].
A prominent role for KLF9 in cellular response to chemo-
therapeutic agents and other cell stressors is suggested
from the present results. As noted above, metal-
lothioneins, which were KLF9-induced, likely have a pro-
tective role during endometrial cell stress [54]. KLF9 over-
expressing HEC-1-A cells had increased mRNA expression
of BCAR3 and PSAT1, proteins previously implicated in
the acquisition of tamoxifen resistance by breast cancer
cells [57,58]. PSAT1 also is involved in the process by
which colon cancer cells acquire chemotherapy resistance
[59]. Expression of the KLF9 gene target SLPI is induced in
endometria of women receiving tamoxifen [60]. Thus,
KLF9 through several of its downstream targets may par-
ticipate in the pathway(s) and network(s) by which
tamoxifen becomes estrogenic and thereby, tumorigenic
for a subset of pre-disposed uterine endometrial epithelial
cells.
KLF9 over-expressing HEC-1-A cells had increased abun-
dance of MAPKAPK3, TRIB3 and ELK3 mRNAs; the corre-
sponding proteins participate in cell stress-response
pathways [61]. Interestingly, MAPKAPK3, a Ser-Thr
kinase, is activated by serum and other growth inducers
and is a point of convergence of ERK, p38MAP kinase and
Jun N-terminal kinase (JNK) signaling pathways [61]. By
inducing expression of MAPKAPK3, KLF9 may enhance
basal and/or overall activity of one or more of these
important pathways. Consistent with these findings, we
previously demonstrated that KLF9 over-expression
caused: 1) HEC-1-A cells to become more mitogenically
responsive to serum and TGF-β1 [21], and 2) the IGFBP2
gene and its promoter to be potently induced by serum
[22]. Moreover, curcumin, an inhibitor of JNK, blocked
the inductive effect of KLF9 on serum-stimulation of the
IGFBP2 gene promoter [22]. Another group has reported
that acetaldehyde induced KLF9 expression in rat hepatic
stellate cells via activation of the JNK pathway [62]. Alto-
gether, these observations invoke KLF9 as a nuclear partic-
ipant in the JNK pathway and the cellular responses that
it subserves. Thus, in keeping with a functional KLF net-
work in endometrial epithelial cells, KLF9 joins its nuclear
brethren, KLF4 and KLF5, as potentially important medi-
ators of cellular stress response [2].
Results implicate KLF9 in the transcriptional regulation of
key pathways that sub-serve proliferation, adhesion,
migration, stress, response to chemotherapeutic agents,
embryo attachment and implantation, and uterine
remodeling. Coupled with the ability of KLF9 to interact
with other members of the Sp/KLF family, progesterone
receptors, and receptor co-activators and co-repressors,
our data suggest expanded possibilities for KLF9 to affect
distinct physiological processes as well as the genesis of
endometrial tumors. Given that KLF9 null mice are viable
with a relatively mild uterine phenotype, further study ofReproductive Biology and Endocrinology 2008, 6:41 http://www.rbej.com/content/6/1/41
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KLF9 is warranted to clearly define its unique functions in
normal uterine biology and in endometrial neoplasia dis-
tinct from those potentially compensated by closely
related KLFs.
Conclusion
Microarray profiling of HEC-1-A sub-lines, differing in rel-
ative expression of KLF9, identified a network of genes
downstream of this transcription factor. The nature of the
participants in this network implicates KLF9 in control of
endometrial cell adhesion to substratum, tumor cell
migration and invasion, cell stress responses, embryo
attachment to endometrium, and uterine remodeling.
Additional studies of the complex, multi-factorial role of
KLF9 in the uterus are therefore warranted.
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